Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-07-11FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental ANDA for doxepin hydrochloride from Mylan Pharmaceuticals Inc., enabling a generic version of the drug to en…
-
FDA label_change · 2007-07-03FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Nortriptyline hydrochloride from Dr. Reddy's Laboratories, resulting in labeling changes for the…
-
FDA approval · 2007-07-03FDA Approved: AMOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for AMOXAPINE submitted by Actavis Pharma, Inc.
-
FDA approval · 2007-07-02FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide (generic) from Aurobindo Pharma Limited under ANDA077812. This expands a…
-
FDA approval · 2007-07-02FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for the generic antidepressant citalopram submitted by Chartwell Governmental & Specialty RX, LL…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-07-02Clinical Trial Update: Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression [Phase 4]
Phase 4 trial comparing duloxetine alone versus duloxetine plus non-drug therapy for depression has completed.
-
FDA approval · 2007-06-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Amitriptyline hydrochloride from Sandoz Inc., enabling regulatory clearance for this generic pro…
-
FDA label_change · 2007-06-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Sun Pharmaceutical to modify the drug's labeling.
-
FDA approval · 2007-06-28FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Citalopram hydrobromide from Aurobindo Pharma Limited.
-
FDA approval · 2007-06-28FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for citalopram.
-
FDA approval · 2007-06-27FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic antidepressant citalopram from Mylan Pharmaceuticals. This approval enables the gene…
-
FDA approval · 2007-06-26FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride from Oxford Pharmaceuticals, LLC.
-
FDA approval · 2007-06-26FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for doxepin hydrochloride from Lannett Company, Inc., authorizing changes to an already approved pro…
-
FDA approval · 2007-06-26FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride submitted by Oxford Pharmaceuticals, LLC.
-
FDA approval · 2007-06-25FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for imipramine hydrochloride from Strides Pharma Science Limited. The approval covers the continued …
-
FDA approval · 2007-06-25FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride (Teva Pharmaceuticals USA, Inc.) under the ANDA program. This action upd…
-
FDA approval · 2007-06-25FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for trazodone hydrochloride (generic), confirming regulatory approval for a change under…
-
FDA approval · 2007-06-25FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for trazodone hydrochloride from Apotex Corp, indicating an approved modification to the product's l…
-
FDA approval · 2007-06-25FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2007-06-21Clinical Trial Update: Duloxetine Versus Paroxetine for Major Depression [Phase 3]
A Phase 3 trial comparing duloxetine and paroxetine for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Combination Therapy in Patients With Depression [Phase 4]
A Phase 4 clinical trial from Eli Lilly evaluating a combination therapy for depressive symptoms has completed.
-
FDA approval · 2007-06-13FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic extended-release formulation of bupropion hydrochloride XL under an original ANDA, typically indicated…
-
CLINICAL_TRIALS trial_result · 2007-06-12Clinical Trial Update: Evaluation of the Effects of Duloxetine on Norepinephrine [Phase 1]
This trial update reports the completion of a Phase 1 study evaluating the effects of duloxetine on norepinephrine in adults with Major Depr…
-
FDA approval · 2007-06-04FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for Bupropion Hydrochloride from Epic Pharma LLC, granting regulatory approval of this generic produ…
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: Modulation of Visually Evoked Potentials by an Antidepressant [NA]
A completed clinical trial from University Hospital Freiburg examined how an antidepressant modulates visually evoked potentials in individu…